Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Courtenay

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
The Canadian Nurse|December 1, 1990
Focusing on wellnessS Bestard, M Courtenay
Immunochemistry|April 1, 1977
Restricted avidity of the IgM antibody response to dextran B512 in mice: studies on inhibition of specific plaque forming cells by oligosaccharidesG Vicari, B M Courtenay
European Journal of Immunology|September 1, 1974
Induction of B cell tolerance to polysaccharides by exhaustive immunization and during immunosuppression with cyclophosphamideJ G Howard, B M Courtenay
The International Journal of Lower Extremity Wounds|May 6, 2005
Maggot debridement therapy for chronic woundsJ C T Church, M Courtenay
Immunology|October 1, 1975
Influence of molecular structure on the tolerogenicity of bacterial dextrans. II. The alpha1--3-linked epitope of dextran B1355J G Howard, B M Courtenay
Diabetic Medicine : a Journal of the British Diabetic Association|August 21, 2010
The views of patients with diabetes about nurse prescribingM Courtenay, K Stenner, N Carey
European Journal of Immunology|November 1, 1976
Lack of effect of thymectomy on spontaneous recovery from tolerance to levanJ G Howard, B M Courtenay, C Hale
Journal of the Royal Society of Medicine|March 31, 2000
Larva therapy in wound managementM Courtenay, J C Church, T J Ryan
European Journal of Immunology|August 1, 1973
Studies on immunological paralysis. XI. A comparison of the tolerogenicity in vitro of levan and type 3 pneumococcal polysaccharideI Kotlarski, B M Courtenay, J G Howard
Immunochemistry|May 1, 1976
Molecular size and structure in relation to the tolerogenicity of small fructosans (levans)C Moreno, B M Courtenay, J G Howard
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
The Canadian Nurse|December 1, 1990
Focusing on wellnessS Bestard, M Courtenay
Immunochemistry|April 1, 1977
Restricted avidity of the IgM antibody response to dextran B512 in mice: studies on inhibition of specific plaque forming cells by oligosaccharidesG Vicari, B M Courtenay
European Journal of Immunology|September 1, 1974
Induction of B cell tolerance to polysaccharides by exhaustive immunization and during immunosuppression with cyclophosphamideJ G Howard, B M Courtenay
The International Journal of Lower Extremity Wounds|May 6, 2005
Maggot debridement therapy for chronic woundsJ C T Church, M Courtenay
Immunology|October 1, 1975
Influence of molecular structure on the tolerogenicity of bacterial dextrans. II. The alpha1--3-linked epitope of dextran B1355J G Howard, B M Courtenay
Diabetic Medicine : a Journal of the British Diabetic Association|August 21, 2010
The views of patients with diabetes about nurse prescribingM Courtenay, K Stenner, N Carey
European Journal of Immunology|November 1, 1976
Lack of effect of thymectomy on spontaneous recovery from tolerance to levanJ G Howard, B M Courtenay, C Hale
Journal of the Royal Society of Medicine|March 31, 2000
Larva therapy in wound managementM Courtenay, J C Church, T J Ryan
European Journal of Immunology|August 1, 1973
Studies on immunological paralysis. XI. A comparison of the tolerogenicity in vitro of levan and type 3 pneumococcal polysaccharideI Kotlarski, B M Courtenay, J G Howard
Immunochemistry|May 1, 1976
Molecular size and structure in relation to the tolerogenicity of small fructosans (levans)C Moreno, B M Courtenay, J G Howard
Pageof 6